Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Parkinsonian Disorders (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinsonian Disorders (diagnostic imaging) < Parkinsonian Disorders (drug therapy) < Parkinsonian Disorders (economics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000173 (2001) G A Metz [Canada] ; T. Farr ; M. Ballermann ; I Q WhishawChronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6-OHDA dopamine-depleted (hemi-Parkinson analogue) rats.
000174 (2001) A H Rajput [Canada]Levodopa prolongs life expectancy and is non-toxic to substantia nigra.
000A48 (2009) Pershia Samadi [Canada] ; Alex Rajput ; Frédéric Calon ; Laurent Grégoire ; Oleh Hornykiewicz ; Ali H. Rajput ; Thèrèse Di PaoloMetabotropic glutamate receptor II in the brains of Parkinsonian patients.
001017 (2011) Yuanyuan Chen [Canada] ; Mazhar Haque ; Eric M. YoshidaTransient improvement of acquired hepatocerebral degeneration with parkinsonian symptoms after failed liver transplant: case report and literature review.
001109 (2012) Connie Marras [Canada] ; Andrea Gruneir ; Paula Rochon ; Xuesong Wang ; Geoff Anderson ; Jonathan Brotchie ; Chaim M. Bell ; Susan Fox ; Peter C. AustinDihydropyridine calcium channel blockers and the progression of parkinsonism.
001221 (2013) Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di PaoloMPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.
001464 (2013) Maria Gabriela Sánchez [Canada] ; Marc Morissette ; Thérèse Di PaoloEstradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.
001473 (2013) Nicolas Morin [Canada] ; Marc Morissette ; Laurent Grégoire ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di PaoloChronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
001668 (2014) Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.
001886 (2014) Sherri L. Thiele [Canada] ; Betty Chen [Canada] ; Charlotte Lo [Canada] ; Tracey S. Gertler [États-Unis] ; Ruth Warre [Canada] ; James D. Surmeier [États-Unis] ; Jonathan M. Brotchie [Canada] ; Joanne E. Nash [Canada]Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
001A44 (2015) Sujoy Phookan [États-Unis] ; Alexander C. Sutton [États-Unis] ; Ian Walling [États-Unis] ; Autumn Smith [États-Unis] ; Katherine A. O'Connor [États-Unis] ; Joannalee C. Campbell [États-Unis] ; Megan Calos [États-Unis] ; Wilson Yu [États-Unis] ; Julie G. Pilitsis [États-Unis] ; Jonathan M. Brotchie [Canada] ; Damian S. Shin [États-Unis]Gap junction blockers attenuate beta oscillations and improve forelimb function in hemiparkinsonian rats.
001A75 (2015) Fariborz Rahimi [Canada] ; Derek Debicki [Canada] ; Angela Roberts-South [Canada] ; Carina Bee [Canada] ; Priya Bapat [Canada] ; Mandar Jog [Canada]Dynamic decomposition of motion in essential and parkinsonian tremor.
001A99 (2015) Laurent Grégoire [Canada] ; Tara Smith [Canada] ; Vijitha Senanayake [Canada] ; Asuka Mochizuki [Japon] ; Edith Miville-Godbout [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada]Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys.
001B30 (2015) Jorge Gandía [Espagne] ; Xavier Morat [Espagne] ; Igor Stagljar [Canada] ; Víctor Fernández-Due As [Espagne] ; Francisco Ciruela [Belgique]Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
001B57 (2015) Vincent A. Jourdain ; Nicolas Morin ; Laurent Grégoire ; Marc Morissette ; Thérèse Di PaoloChanges in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinsonian Disorders (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinsonian Disorders (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinsonian Disorders (drug therapy)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022